Barclays’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-26,003
Closed -$367K 5507
2025
Q2
$367K Sell
26,003
-143,100
-85% -$2.2M ﹤0.01% 3930
2025
Q1
$2.9M Buy
169,103
+52,992
+46% +$987K ﹤0.01% 2353
2024
Q4
$2.23M Buy
116,111
+2,085
+2% +$39.4K ﹤0.01% 2802
2024
Q3
$2.11M Sell
114,026
-17,132
-13% -$318K ﹤0.01% 2806
2024
Q2
$2.46M Buy
+131,158
New +$2.34M ﹤0.01% 1996

Other funds holding CCAP

Barclays's CCAP Position: Q3 2025 in Review

Barclays sold out of Crescent Capital BDC (CCAP) in Q3 2025, closing a stake of 26,003 shares — an estimated $367K sold.

Barclays first reported a position in CCAP in Q2 2024 and held it in 5 quarters. The position peaked at $2.9M in Q1 2025. 93 funds tracked by Wall St. Rank hold CCAP as of Q3 2025.

  • Barclays reported no remaining Crescent Capital BDC position as of Q3 2025 after selling out during the quarter.
  • Barclays sold 26,003 Crescent Capital BDC shares in Q3 2025, an estimated $367K.
  • Barclays first reported a position in Crescent Capital BDC in Q2 2024 and held it in 5 quarters.
  • Barclays's Crescent Capital BDC position peaked at $2.9M in Q1 2025.
  • 93 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q3 2025.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.